Heska introduces ThyroMed? chewable tablets for the treatment of canine hypothyroidism.
Heska introduces ThyroMed™ chewable tablets for the treatment of canine hypothyroidism. They contain the proven active ingredient levothyroxine sodium and have equivalent efficacy to other levothyroxine sodium supplements, the company says.
The chewable tablets are easy to administer, the company adds, increasing client compliance.
ThyroMed tablets have eight available strengths 0.1 mg.-0.8mg. in two childproof bottle sizes 1,000 and 180-count.
For fastest response, call